About

The startup develops a diabetes therapy drug that utilizes a naturally occurring protein to regulate blood sugar levels, providing a potential alternative to traditional insulin therapy. This approach aims to enhance patient safety and efficacy, offering a therapeutic option that reduces reliance on insulin for diabetes management.

What does do?

The startup develops a diabetes therapy drug that utilizes a naturally occurring protein to regulate blood sugar levels, providing a potential alternative to traditional insulin therapy. This approach aims to enhance patient safety and efficacy, offering a therapeutic option that reduces reliance on insulin for diabetes management.

Where is located?

is based in Geneva, United States.

When was founded?

was founded in 2022.

Location
Geneva, United States
Founded
2022
0

Find Investable Startups and Competitors

Search thousands of startups using natural language

⚠️ AI-generated overview based on web search data – may contain errors, please verify information yourself! You can claim this account with your email domain to make edits.

Executive Summary

The startup develops a diabetes therapy drug that utilizes a naturally occurring protein to regulate blood sugar levels, providing a potential alternative to traditional insulin therapy. This approach aims to enhance patient safety and efficacy, offering a therapeutic option that reduces reliance on insulin for diabetes management.

diatheris.com
Founded 2022Geneva, United States

Funding

No funding information available.

Team

No team information available.
Want to add first party data to your startup here or get your entry removed? You can edit it yourself by logging in with your company domain.